{"transactions":[{"id":4330261,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":172442,"kind":"person","name":"Redmont VAXN Capital Holdings, LLC","position":2,"cik":"0001705638","reported_name":"Redmont VAXN Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176393,"kind":"organization","name":"Redmont Venture Partners, Inc.","position":3,"cik":"0001705639","reported_name":"Redmont Venture Partners, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176392,"kind":"organization","name":"Paradigm Venture Partners, L.P.","position":4,"cik":"0001705640","reported_name":"Paradigm Venture Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-05-08T20:37:18.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":4455,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001 on a 0.749106:1 basis upon the closing of the merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Consists of shares of Common Stock held by Paradigm Venture Partners, L.P., a Delaware limited partnership (\"PVP\").  Mr. Hodges has sole voting and dispositive control with respect to all securities held by PVP. Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":4455,"source":{"system":"sec-edgar","filing":"0000899243-17-012362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705638/000089924317012362/doc4.xml","form_type":"4"}},{"id":4330260,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":172442,"kind":"person","name":"Redmont VAXN Capital Holdings, LLC","position":2,"cik":"0001705638","reported_name":"Redmont VAXN Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176393,"kind":"organization","name":"Redmont Venture Partners, Inc.","position":3,"cik":"0001705639","reported_name":"Redmont Venture Partners, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176392,"kind":"organization","name":"Paradigm Venture Partners, L.P.","position":4,"cik":"0001705640","reported_name":"Paradigm Venture Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-05-08T20:37:18.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":36785,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001 on a 0.749106:1 basis upon the closing of the merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of shares of Common Stock held by Redmont Venture Partners, Inc., a Delaware corporation (\"RVP\").  Mr. Hodges has sole voting and dispositive control with respect to all securities held by RVP.  Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":36785,"source":{"system":"sec-edgar","filing":"0000899243-17-012362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705638/000089924317012362/doc4.xml","form_type":"4"}},{"id":4330259,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":172442,"kind":"person","name":"Redmont VAXN Capital Holdings, LLC","position":2,"cik":"0001705638","reported_name":"Redmont VAXN Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176393,"kind":"organization","name":"Redmont Venture Partners, Inc.","position":3,"cik":"0001705639","reported_name":"Redmont Venture Partners, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176392,"kind":"organization","name":"Paradigm Venture Partners, L.P.","position":4,"cik":"0001705640","reported_name":"Paradigm Venture Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-05-08T20:37:18.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1278471,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001 on a 0.749106:1 basis upon the closing of the merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of shares of Common Stock held by Redmont VAXN Capital Holdings, LLC, a Delaware limited liability company (\"RVCH\").  Philip Hodges has sole voting and dispositive control with respect to all securities held by RVCH.  Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":1278471,"source":{"system":"sec-edgar","filing":"0000899243-17-012362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705638/000089924317012362/doc4.xml","form_type":"4"}}]}